The Fas signaling pathway is functional in colon carcinoma cells and induces apoptosis

Clinical Cancer Research

Volumn 3, Issue 12 I, 1997, Pages 2205-2209

  Houghton, Janet A ^a   Harwood, Franklin G ^a   Gibson, Alice A ^a   Tillman, David M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; COLON CARCINOMA; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; CARRIER PROTEINS; CELL SURVIVAL; COLONIC NEOPLASMS; HUMANS; PROTEIN-TYROSINE-PHOSPHATASE; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; THYMIDYLATE SYNTHASE; TUMOR CELLS, CULTURED;

EID: 0031427452     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. French, L. E., Hahne, M., Viard, I., Radlgruber, G., Zanone, R., Becker, K., Muller, C., and Tschopp, J. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turn-over. J. Cell Biol., 133: 335-343, 1996.
2. Peter, M. E., Kischkel, F. C., Hellbardt, S., Chinnaiyan, A. M., Krammer, P. H., and Dixit, V. M. CD95 (APO-1/Fas)-associated signalling proteins. Cell Death Differ., 3: 161-170, 1996.
3. Leithauser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Bruderlein, S., Henne, C., Schmidt, A., Debatin, K-M., Krammer, P. H., and Moller, P. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor superfamily, in normal and neoplastic cells. Lab. Invest., 69: 415-429, 1993.
4. Moller, P., Koretz, K., Leithauser, F., Bruderlein, S., Henne, C., Quentmeier, A., and Krammer, P. Expression of Apo-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int. J. Cancer, 57: 371-377, 1994.
5. Meterissian, S., and Kontogiannea, M. Fas antigen expression and function in human colorectal carcinoma. Correlation with Bcl-2 expression. Proc. Am. Assoc. Cancer Res., 37: 15, 1996.
6. Houghton, J. A., Tillman, D. M., and Harwood, F. G. Ratio of 2′-deoxyadenosine-5′-triphosphate/thymidine-5′-triphosphate influences the commitment of human colon carcinoma cells to thymineless death. Clin. Cancer Res., 1: 723-730, 1995.
7. Harwood, F. G., Frazier, M. W., Krajewski, S., Reed, J. C., and Houghton, J. A. Acute and delayed apoptosis induced by thymidine deprivation correlates with expression of p53 and p53-regulated genes in colon carcinoma cells. Oncogene, 12: 2057-2067, 1996.
8. Seto, M., Jaeger, U., Hockett, R. D., Graninger, W., Bennett, S., Goldman, P., and Korsmeyer, S. J. Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2Ig fusion gene in lymphoma. EMBO J., 7: 123-131, 1988.
9. Becker, T. C., Noel, R. J., Coats, W. S., Gomez-Foix, A. M., Alam, T., Gerard, R. D., and Newgard, C. B. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol., 43: 161-189, 1994.
10. O'Connell, J., O'Sullivan, G. C., Collins, J. K., and Shanahan, F. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med., 184: 1075-1082, 1996.
11. Sato, T., Irie, S., Kitada, S., and Reed, J. C. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science (Washington DC), 268: 411-415, 1995.
12. Bargou, R. C., Wagener, C., Bommert, K., Mapara, M. Y., Daniel, P. T., Arnold, W., Dietel, M., Guski, H., Feller, A., Royer, H. D., and Dorken, B. Overexpression of the death-promoting gene bax-α, which is down-regulated in breast cancer, restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. J. Clin. Invest., 97: 2651-2659, 1996.
13. Jaattela, M., Benedict, M., Tewari, M., Shayman, J. A., and Dixit, V. M. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene, 10: 2297-2305, 1995.
14. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, P. H., Peter, M. E., and Dixit, V. M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell, 85: 817-827, 1996.
15. Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I. A. G., Debatin, K. M., Fischer, A., and de Villarty, J. P. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science (Washington DC), 268: 1347-1349, 1995.
16. Wu, J., Wilson, J., He, J., Xiang, L., Schur, P. H., and Mountz, J. D. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J. Clin. Invest., 98: 1107-1113, 1996.
17. Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., and Mountz, J. M. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science (Washington DC), 263: 1759-1762, 1994.
18. Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, A. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W-W., Kruzel, E., and Radinsky, R. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol., 15: 3032-3040, 1995.
19. Tamura, T., Aoyama, N., Saya, H., Haga, H., Futami, S., Miyamoto, M., Koh, T., Ariyasu, T., Tachi, M., Kasuga, M., and Takahashi, R. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells. Oncogene, 11: 1939-1946, 1995.